- Condition: Cardiovascular Disease
Intervention: Dietary Supplement: High/ Low Epicatechin Apples/ Apple Extract/ Granules
Sponsors: Queen's University, Belfast; Queen's University, Belfast
Recruiting - verified April 2012 - Condition: Labouring Parturients Requiring/Requesting Epidural Analgesia as Part of Their Peri-partum Care
Intervention: Device: Epidrum
Sponsors: National Maternity Hospital, Ireland; National Maternity Hospital, Ireland
Recruiting - verified April 2012 - Condition: Enteral Feeds
Interventions: Dietary Supplement: Caseinate; Dietary Supplement: Milk Protein Isolate
Sponsors: University College Cork; University College Cork
Completed - verified May 2012 - Condition: Fractured Neck of Femur
Interventions: Drug: Dexamethasone acetate; Drug: Placebo
Sponsors: Cork University Hospital; Cork University Hospital; University of Bristol
Recruiting - verified March 2012 - Condition: Dietary Modification
Interventions: Behavioral: Level 1 Dietary Intake; Behavioral: Level 2: Dietary Intake + Phenotype; Behavioral: Level 3 Dietary + Phenotype + Genotype; Behavioral: Level 0 Control Group
Sponsors: Newcastle University; Newcastle University; University College Dublin; Maastricht University; University of Oslo; University of Navarra; Harokopio University; University of Reading; National Food and Nutrition InstitutE; Technische Universität München; University of Newcastle Upon-Tyne
Not yet recruiting - verified February 2012 - Conditions: Obesity; Diabetes; Cardiovascular Diseases
Interventions: Dietary Supplement: Olive oil; Dietary Supplement: Olive oil and fish powder; Dietary Supplement: Olive oil and macadamia oil; Dietary Supplement: Deadaptation
Sponsors: University of Limerick; University of Limerick
Completed - verified January 2012 - Conditions: Food Allergy; Eczema; Obesity
Intervention:
Sponsors: National Children's Research Centre, Ireland; National Children's Research Centre, Ireland; Food Standards Agency, United Kingdom
Active, not recruiting - verified December 2011 - Condition: Overweight
Interventions: Drug: 120 mg orlistat; Drug: 60 mg orlistat; Drug: orlistat experimental dose
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified April 2012 - Condition: Malaria
Interventions: Biological: ChAd63 CS; Biological: ChAd63 CS, MVA CS; Biological: ChAd63 CS; Biological: ChAd63, MVA CS
Sponsors: University of Oxford; University of Oxford
Recruiting - verified December 2011 - Condition: Tobacco Dependence
Interventions: Drug: Nicotine; Drug: Nicotine; Drug: Nicotine
Sponsors: Johnson & Johnson Consumer and Personal Products Worldwide; Johnson & Johnson Consumer and Personal Products Worldwide
Completed - verified September 2011 - Condition: Vitamin D Status as Reflected by Serum 25-hydroxyvitamin D
Interventions: Dietary Supplement: vitamin D3; Dietary Supplement: 25-hydroxyvitamin D3; Dietary Supplement: 25-hydroxyvitamin D (20 microgram/day); Dietary Supplement: Placebo
Sponsors: University College Cork; University College Cork
Active, not recruiting - verified June 2011 - Condition: Healthy Volunteer
Interventions: Drug: Paracetamol formulation 1; Drug: Paracetamol formulation 2
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified March 2012 - Condition: Osteoarthritis
Interventions: Dietary Supplement: AquaCal; Dietary Supplement: AquaPT
Sponsors: University College Cork; Andrea Doolan
Completed - verified May 2012 - Condition: Unspecified Threat to Breathing
Intervention:
Sponsors: BiancaMed Ltd; BiancaMed Ltd
Completed - verified March 2011 - Condition: Uterine Hemorrhage
Interventions: Drug: Tranexamic acid; Drug: Mefenamic acid; Drug: Placebo; Drug: Mirena (Levonorgestrel IUS, BAY86-5028)
Sponsors: Bayer; Bayer
Completed - verified February 2012 - Conditions: Acupuncture; Morphine Induced Pruritis
Interventions: Device: ACUPUNCTURE AT LI11; Device: SHAM ACUPUNCTURE
Sponsors: Letterkenny General Hospital; Letterkenny General Hospital
Completed - verified January 2011 - Condition: Colorectal Cancer
Intervention: Device: EndoVe endoscopic electroporation
Sponsors: Mercy University Hospital, Cork, Ireland; Mercy University Hospital, Cork, Ireland
Recruiting - verified September 2011 - Condition: Postoperative Nausea and Vomiting
Intervention: Other: fluid administration
Sponsors: The Rotunda Hospital; The Rotunda Hospital
Completed - verified May 2010 - Condition: Respiratory Tract Infections
Interventions: Drug: Paracetamol 500 mg/Phenylephrine 5 mg tablets; Drug: Paracetamol 1000 mg/Phenylephrine 10 mg sachet
Sponsors: Johnson & Johnson Consumer and Personal Products Worldwide; Johnson & Johnson Consumer and Personal Products Worldwide
Completed - verified October 2011 - Condition: Traveler's Diarrhea
Interventions: Biological: TD Vaccine System; Biological: TD Vaccine System
Sponsors: Intercell USA, Inc.; Intercell USA, Inc.
Completed - verified January 2012 - Condition: Travelers' Diarrhea
Interventions: Biological: TD Vaccine System; Biological: TD Vaccine System
Sponsors: Intercell USA, Inc.; Intercell USA, Inc.
Completed - verified March 2012 - Condition: Giant Cell Arteritis
Interventions: Procedure: Ultrasound of temporal and axillary arteries; Procedure: Temporal artery biopsy
Sponsors: University of Oxford; University of Oxford; University of Sheffield; Southend University Hospital; Nuffield Orthopaedic Centre NHS Trust; John Radcliffe Hospital; The Leeds Teaching Hospitals NHS Trust; University of Bristol; London School of Hygiene and Tropical Medicine; Medical Center for Rheumatology Berlin-Buch
Recruiting - verified January 2012 - Conditions: Self Concept; Body Fat Composition; Depression; Perceived Social Support
Interventions: Other: Exercise; Behavioral: Online Cognitive Behavioural Therapy
Sponsors: Dublin City University; Dublin City University
Completed - verified July 2011 - Conditions: Prostate Cancer; Sexual Dysfunction
Interventions: Drug: tadalafil; Other: placebo
Sponsors: National Cancer Institute (NCI); Radiation Therapy Oncology Group; National Cancer Institute (NCI)
Active, not recruiting - verified February 2012 - Condition: Healthy
Intervention: Drug: ibuprofen
Sponsors: Johnson & Johnson Consumer and Personal Products Worldwide; Johnson & Johnson Consumer and Personal Products Worldwide
Completed - verified October 2011 - Condition: Healthy
Intervention: Drug: ivermectin
Sponsors: Johnson & Johnson Consumer and Personal Products Worldwide; Johnson & Johnson Consumer and Personal Products Worldwide
Completed - verified October 2011 - Condition: Cardiovascular Disease
Intervention: Other: Fruit and vegetable intervention
Sponsors: Queen's University, Belfast; Queen's University, Belfast
Completed - verified August 2011 - Conditions: Cognition; Aging
Interventions: Drug: tamoxifen; Drug: raloxifene
Sponsors: Wake Forest University; Wake Forest University; National Institute on Aging (NIA)
Completed - verified May 2008 - Conditions: Lung Cancer; Malnutrition; Weight Changes
Interventions: Other: physiologic testing; Other: questionnaire administration; Procedure: management of therapy complications; Radiation: radiation therapy
Sponsors: Case Comprehensive Cancer Center; Case Comprehensive Cancer Center; National Cancer Institute (NCI)
Withdrawn - verified July 2011 - Condition: Premature Ejaculation
Intervention: Drug: 16448
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified February 2011 - Condition: Human Immunodeficiency Virus Infections
Interventions: Drug: lopinavir/ritonavir (LPV/r) (tablet or capsule) with nucleoside reverse transcriptase inhibitors (NRTIs); Drug: lopinavir/ritonavir (LPV/r) (tablet or capsule) with nucleoside reverse transcriptase inhibitors (NRTIs); Drug: lopinavir/ritonavir (LPV/r) (tablet or capsule) with nucleoside reverse transcriptase inhibitors (NRTIs); Drug: lopinavir/ritonavir (LPV/r) (tablet or capsule) with nucleoside reverse transcriptase inhibitors (NRTIs)
Sponsors: Abbott; Abbott
Completed - verified February 2012 - Condition: Breast Cancer
Intervention: Drug: anastrozole
Sponsors: Queen Mary University of London; Jill Knox
Active, not recruiting - verified April 2012


